Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.

P. van der Leest, B. Hiddinga, A. Miedema, Aguirre M. L. Azpurua, N. Rifaela, A. ter Elst, W. Timens, H. J. M. Groen, L. C. van Kempen, T. J. N. Hiltermann

Onderzoeksoutput

53 Downloads (Pure)

Samenvatting

The following error appeared in Section 3.5 in Ref. [1]. Instead of ‘Progressive disease-L1 expression data were available for 87 patients’, the text should read ‘PD-L1 expression data were available for 87 patients’. We apologize for this error.

Originele taal-2English
Pagina's (van-tot)310-310
Aantal pagina's1
TijdschriftMolecular oncology
Volume16
Nummer van het tijdschrift1
DOI's
StatusPublished - jan.-2022

Vingerafdruk

Duik in de onderzoeksthema's van 'Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.'. Samen vormen ze een unieke vingerafdruk.

Citeer dit